In summary, these results indicate that both treatments are
superior to OMC and provide widened choices for all
patients. The selection of the ideal treatment will depend on
the patient’s preference. At the very least, the CLEVER
6-month results suggest that SE is a reasonable strategy
compared with ST and that efforts should be made to develop
SE programs that are available and affordable to patients.